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Introduction: The Yangtze river delta in eastern China, centered on Shanghai, is one of 
the most populated regions of the world with more than 100 million residents. We 
examined the impact of influenza on excess mortality in Yancheng, a prefecture- level 
city with 8.2 million population located 250 km north of Shanghai, during 
2011- 2015.
Methods: We obtained individual data on deaths by date, age, sex, and cause in 
Yancheng from the Chinese Centers for Disease Control and Prevention, and used 
these to derive weekly rates of mortality from respiratory causes, respiratory and car-
diovascular causes combined, and all causes. We used data on influenza- like illnesses 
and laboratory detections of influenza to construct a proxy measure of the weekly 
incidence of influenza virus infections in the community. We used regression models 
to estimate the association of influenza activity with mortality and excess mortality by 
age, cause, and influenza type/subtype.
Results: We estimated that an annual average of 4.59 (95% confidence interval: 3.94, 
7.41) excess respiratory deaths per 100 000 persons were associated with influenza, 
which was 4.6% of all respiratory deaths in the years studied. Almost all influenza- 
associated excess deaths occurred in persons ≥65 years. Influenza A(H3N2) had the 
greatest impact on mortality and was associated with around 50% of the influenza- 
associated respiratory deaths in the 5 years studied.
Conclusions: Influenza has a substantial impact on respiratory mortality in Yancheng, 
mainly in older adults. Influenza vaccination has the potential to reduce disease bur-
den, and cost- effectiveness analysis could be used to compare policy options.
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1  | INTRODUCTION
Influenza virus infections cause substantial morbidity and mortality in 
annual winter epidemics in temperate locations.1 Most influenza virus in-
fections are never laboratory- confirmed, including even those that result 
in hospitalization or death.2 Therefore, the preferred approach to quan-
tify the mortality impact of influenza epidemics is statistical modeling 
of time series of mortality rates.3 Many studies examine the impact of 
influenza on deaths with respiratory codes.3,4 However, because death 
coding practices can vary by location, and because influenza can cause 
deaths that are not coded as respiratory,3 it can be informative to include 
cardiovascular deaths,5 and also to examine all- cause mortality.3,6
China is the most populous country in the world with a population 
of 1.4 billion, and there are now more than 100 cities in China with a 
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population between 1 and 10 million, in addition to the six megacities of 
Shanghai, Beijing, Tianjin, Guangzhou, Shenzhen and Chengdu. Yancheng 
is one such city with a population of 7.3 million in the 2010 census, and 
a gross domestic product of 58 300 RMB (8750 USD) per capita in 2015. 
Yancheng is situated in Jiangsu province, just north of the Yangtze river 
delta in eastern China where more than 100 million people are clus-
tered in the area surrounding Shanghai (Figure 1). Jiangsu province has 
a subtropical- like pattern in influenza virus activity with a less obvious 
seasonal pattern, compared to the temperate northern part of the coun-
try where there are influenza epidemics each winter, and the southern 
provinces where there are summer epidemics.7 Limited attention has so 
far been given to the potential burden of influenza in Yancheng, as with 
most other cities in China, and influenza vaccine coverage is very low. We 
conducted this study to estimate the influenza- associated excess mortal-
ity burden in Yancheng city in the years 2011 through 2015.
2  | METHODS
2.1 | Sources of data
We obtained individual data on deaths by date, age, sex and cause 
from the Administrative System of Death Records, which form part 
of the Information System of the Chinese Centers for Disease Control 
and Prevention. The 10th revision of the International Statistical 
Classification of Diseases and Related Health Problems (ICD- 10) was 
used to code the causes of death. We compiled the weekly numbers 
of deaths from respiratory causes (ICD- 10 codes J00- J99), cardio-
vascular and respiratory causes combined (ICD- 10 codes I00- I99 and 
J00- J99), and all causes, by three age groups: 0- 14 years, 15- 64 years, 
and ≥65 years. Data on the underlying population structure by age 
and sex from 2011 to 2015 were obtained from the Yancheng Bureau 
of Statistics, allowing us to derive weekly mortality rates. Influenza 
surveillance data were collected by the Chinese Influenza Surveillance 
Information System, a national system which includes sentinel sites 
in Yancheng, including the weekly rate of influenza- like illnesses in 
sentinel hospitals and the weekly proportion of laboratory speci-
mens testing positive for influenza by type/subtype in Yancheng. 
We multiplied together the weekly influenza- like illness rate and the 
weekly  influenza detection rates to obtain proxy measures of the 
weekly incidence rate of influenza virus infections in the community 
for each type and subtype.8,9 Because of relatively small numbers 
of detections, we smoothed this time series using a moving aver-
age with a bandwidth of 5 weeks (Figure S1 in Appendix S1). Data 
on weekly humidity and temperature were obtained from the China 
Meteorological Data Service Center.
2.2 | Statistical methods
We assumed that the influenza activity proxy was a linear correlate 
of the incidence of infections, and we consequently assumed that 
there would be a linear association between weekly influenza activity 
and weekly influenza- associated mortality.3,4 Based on these assump-
tions, we constructed linear regression models for the mortality rates, 
including the influenza incidence proxies as covariates and an iden-
tity link between the mean mortality rate and the effects of covari-
ates.3,4,10-13 The smoothed virus activity data were used in the main 
analysis for estimation of excess mortality, and the original virus data 
were also applied to the same model in a sensitivity analysis for com-
parison. The models also included temperature and absolute humid-
ity. Because of the average delay between infections and consequent 
mortality, we lagged the incidence proxy by 2 weeks14 and exam-
ined the results with 0- week and 1- week lags in sensitivity analyses. 
Excess deaths were estimated by comparing the predicted mortality 
rates under the model with activity proxies set to zero with the pre-
dicted rates with activity proxies set to their observed values.3,4 We 
estimated excess influenza- associated mortality overall and by age, 
cause- of- death groupings, and influenza type/subtype. The 95% con-
fidence intervals (CIs) for excess mortality rates were estimated with a 
bootstrap approach.3,4 To permit comparison with other countries, ex-
cess mortality rates were directly standardized to the World Standard 
Population.15 More details of the statistical model are available in the 
Appendix S1. Statistical analyses were conducted in R version 3.2.3 (R 
Foundation for Statistical Computing, Vienna, Austria).
3  | RESULTS
In the 5 years studied, a total of 266 873 deaths were recorded, in-
cluding 41 207 coded as respiratory deaths, and 132 166 as cardio-
vascular or respiratory deaths. Influenza epidemics occurred in most 
winters and in the summer of 2015 (Figure 2). We fitted regression 
models in each age group and overall, and these models were able to 
capture patterns in respiratory mortality (Figure 3). We estimated that 
an annual average of 4.59 (95% confidence interval, CI: 3.94, 7.41) 
excess respiratory deaths per 100 000 persons were associated with 
influenza, almost all of which occurred in older adults ≥65 years of 
age (Table 1). This corresponded to an annual average of 378 (95% 
CI: 325, 610) respiratory deaths and 572 (95% CI: 235, 1176) all- 
cause deaths in all ages in Yancheng. The influenza- associated res-
piratory deaths corresponded to 4.6% of all respiratory deaths, and 
F IGURE  1 Location of Yancheng in eastern China, just to the 
north of Shanghai
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the influenza- associated all- cause deaths corresponded to 1.1% of 
all deaths during the study period. Among older adults ≥65 years of 
age, our estimates corresponded to 4.6% of respiratory deaths and 
1.2% of all deaths. When standardizing the age- specific excess mor-
tality rates to the World Standard Population, the age- standardized 
excess influenza- associated respiratory mortality rate was 3.21 (95% 
CI: 1.67, 4.77) per 100 000 persons.
In general, there was an increase in estimated excess influenza- 
associated mortality with broader cause- of- death groupings (Table 1), 
except in children 0- 14 years of age where there was negligible ex-
cess mortality. When broken down by influenza type/subtype, influ-
enza A(H3N2) had the greatest impact during our study period with 
an average of 2.31 (95% CI: 1.66, 3.83) excess respiratory deaths per 
100 000 persons (Table 2), and 3.44 (95% CI: 0.74, 7.32) excess all- 
cause deaths per 100 000 persons (Table 3). This was around 50% 
(2.31/4.59) of all influenza- associated respiratory deaths. Influenza 
A(H3N2) predominated in most of the 5 years studied, including 2012, 
2013, 2014, and 2015, and influenza had generally greater impact in 
the final 3 years studied (Table 4).
In sensitivity analyses, the average annual influenza- associated 
respiratory excess mortality was estimated to be 3.10 (95% CI: 2.06, 
4.28) per 100 000 persons from the model with the original virus 
data, largely similar to the main analysis with the smoothed virus data 
(Tables S4, S5 and S6 in Appendix S1). The main estimates were also 
generally similar to those from the models with a lag of 1 week and 
0 week; that is, influenza was associated with 4.58 (95% CI: 3.70, 7.47) 
and 4.34 (95% CI: 2.99, 7.98) excess respiratory deaths per 100 000 
persons, respectively (Tables S1a- b, S2a- b and S3a- b in Appendix S1).
4  | DISCUSSION
We estimated an average of 4.59 (95% CI: 3.94, 7.41) excess res-
piratory deaths per 100 000 persons in Yancheng (Table 1), which is 
quite consistent with estimates for the impact of influenza across the 
whole of China,2 Hong Kong,4,16 and other locations.6,10,17 This cor-
responded to 4.6% of all respiratory deaths during the study period, 
again consistent with what has been reported elsewhere, for example, 
6.0% in Hong Kong,4 2% in the United States,17 3.2% in Australia,18 
and 4.1% in Bangkok.10 Variation in this fraction would be affected to 
some degree by differences in coding practices between locations.6 
The impact of influenza was estimated to be even greater when incor-
porating the impact on cardiovascular deaths and all- cause mortality 
(Table 1).
The majority of excess deaths were estimated to occur in older 
adults (Table 1). This is consistent with the findings of other studies;6 
for example, 95%, 86%, and 94% of influenza- associated excess re-
spiratory mortality were estimated to occur in this group in studies in 
Hong Kong,4 China,2 and the United States, respectively.17 Influenza 
vaccination is available through the private market in Yancheng, and 
vaccination coverage is currently very low in all age groups. Our results 
indicate the potential for influenza vaccination to reduce the mortal-
ity impact of influenza particularly in older adults. Cost- effectiveness 
analysis could be used to compare policy options.
We identified a greater impact of influenza A(H3N2) compared to 
influenza A(H1N1) and influenza B (Table 2, Table 3), which is similar 
to most other locations.3,4,6,17,19,20 However, this observation is some-
what different to a previous study that estimated influenza B had a 
greater impact than influenza A(H3N2) in China, in the years 2003- 
08.2 We note that the impact of each influenza type/subtype would 
depend to some extent in patterns in circulation; our study included 
5 years of data with variable circulation of A(H1N1), A(H3N2), and B, 
and two major influenza A(H3N2) epidemics in 2013- 14 and 2015 
(Figure 2).
F IGURE  2  Influenza activity by influenza type/subtype in 
Yancheng, 2011- 15. We measured weekly influenza activity by 
multiplying together the weekly rate of influenza- like illnesses 
in sentinel surveillance locations with the weekly proportion 
of laboratory specimens testing positive for influenza by type/
subtype. The resulting indicator of influenza activity is assumed to 
be a correlate of the incidence of influenza virus infections in the 
population. The plot here shows the smoothed data that were used in 
the regression models
TABLE  1 Estimates of the influenza- associated annual excess mortality rates by age and by cause of death in Yancheng, 2011- 2015
Cause of death
Average influenza- associated mortality rate (per 100 000 population per year)
0- 14y (95% CI) 15- 64y (95% CI) ≥65y (95% CI) All ages (95% CI)
Respiratory diseases − 0.06 (−0.39, 0.22) 0.46 (0.26, 0.90) 35.63 (30.53, 57.34) 4.59 (3.94, 7.41)
Cardiovascular and 
respiratory diseases
− 0.08 (−0.47, 0.27) 1.29 (0.74, 2.63) 45.86 (26.36, 89.68) 6.43 (4.06, 12.31)
All causes 0.52 (−1.06, 2.07) 0.74 (−0.80, 2.73) 49.57 (19.80, 102.50) 6.94 (2.85, 14.28)
CI, confidence interval.
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In this study, respiratory excess deaths accounted for most of the 
influenza- associated mortality in Yancheng, while the estimated car-
diovascular excess deaths were less than half of the respiratory excess 
deaths. A large variation was observed in the relative contribution of 
respiratory diseases or cardiovascular diseases to the overall influenza- 
associated excess mortality in different studies.3,4,6,19 Further investi-
gations may be needed to explore the potential reasons accounting for 
differences in the estimates across studies.6
There are a few limitations of our study. First, our results are de-
pendent on the coding and registration of deaths, and errors in attri-
bution of cause of death, which were used as the outcome time series 
in our analyses. We did examine all- cause mortality as a reference 
point for the estimated effects on respiratory mortality and respira-
tory and cardiovascular mortality. Second, our results are also depen-
dent on the measure of the incidence of influenza virus infections in 
the underlying population, which we based on clinical and laboratory 
F IGURE  3 Observed weekly respiratory 
mortality rates (dots) and modeled rates 
with influenza activity (red) and with 
influenza activity set to zero (blue), in three 
age groups and in all ages. The difference 
between the red and blue lines was used 
to estimate the influenza- associated 
respiratory mortality. The lowest panel 
shows the influenza activity proxy
TABLE  2 Estimates of excess influenza- associated respiratory mortality rates by age and by influenza type/subtype in Yancheng, 
2011- 2015
Influenza type/subtype
Average influenza- associated mortality rate (per 100 000 population per year)
0- 14y (95% CI) 15- 64y (95% CI) ≥65y (95% CI) All ages (95% CI)
Influenza A(H1N1) 0.05 (−0.09, 0.25) 0.14 (0.01, 0.37) 12.25 (7.47, 23.58) 1.58 (0.96, 3.04)
Influenza A(H3N2) −0.08 (−0.27, 0.10) 0.11 (−0.05, 0.33) 18.68 (14.22, 31.05) 2.31 (1.66, 3.83)
Influenza B −0.04 (−0.25, 0.15) 0.21 (0.05, 0.45) 4.70 (−2.59, 15.07) 0.71 (−0.23, 2.06)
All influenza −0.06 (−0.39, 0.22) 0.46 (0.26, 0.90) 35.63 (30.53, 57.34) 4.59 (3.94, 7.41)
CI, confidence interval.
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surveillance data (Figure 2). While we were aware that Poisson family 
models are conventionally used for statistical modeling of count data 
and incidence rates,21 we considered the mechanism by which influ-
enza incidence leads to deaths and hypothesized that there should be 
a linear correlation between incidence and mortality.3 We therefore 
used an identity link rather than a logarithmic link to relate incidence 
to mortality in our model, as many others have done.3,4,6,10-13 We 
used a normal error distribution, but results would have been similar 
with a Poisson family error distribution as the numbers of deaths each 
week were not small. Finally, we only examined the impact of influ-
enza epidemics on excess mortality. Influenza epidemics also cause a 
substantial health impact on hospitalizations and outpatient medical 
consultations, and consequent economic impact including healthcare 
costs and lost productivity. A more comprehensive assessment of the 
impact of influenza could further inform public health strategies in-
cluding the use of vaccination.
In conclusion, we documented a substantial burden of influenza in 
Yancheng, and it is likely that a similar burden occurs in other cities in eastern 
China where vaccination coverage is very low. These estimates of influenza- 
associated mortality can be used to guide public health policy decisions. Our 
results highlight the important burden of influenza virus in older adults and 
the potential for influenza vaccination to reduce disease burden.
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